The translational factor eIF3f: the ambivalent eIF3 subunit

被引:38
|
作者
Marchione, Roberta [1 ]
Leibovitch, Serge A. [2 ]
Lenormand, Jean-Luc [1 ]
机构
[1] Univ Grenoble 1, CNRS UMR5525, HumProTher Lab, TheREx,TIMC IMAG Lab, F-38700 La Tronche, France
[2] INRA UM II, UMR DMEM 866, Lab Genom Fonct & Myogenese, F-34060 Montpellier 1, France
关键词
Apoptosis; Atrophy; Cancer; eIF3f; Hypertrophy; INITIATION-FACTOR; 3; SKELETAL-MUSCLE ATROPHY; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC TRANSLATION; CELL-CYCLE; PROTEIN-SYNTHESIS; 26S PROTEASOME; RNA-BINDING; RABBIT RETICULOCYTES; COMPLEX;
D O I
10.1007/s00018-013-1263-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The regulation of the protein synthesis has a crucial role in governing the eukaryotic cell growth. Subtle changes of proteins involved in the translation process may alter the rate of the protein synthesis and modify the cell fate by shifting the balance from normal status into a tumoral or apoptotic one. The largest eukaryotic initiation factor involved in translation regulation is eIF3. Amongst the 13 factors constituting eIF3, the f subunit finely regulates this balance in a cell-type-specific manner. Loss of this factor causes malignancy in several cells, and atrophy in normal muscle cells. The intracellular interacting partners which influence its physiological significance in both cancer and muscle cells are detailed in this review. By delineating the global interaction network of this factor and by clarifying its intracellular role, it becomes apparent that the f subunit represents a promising candidate molecule to use for biotherapeutic applications.
引用
收藏
页码:3603 / 3616
页数:14
相关论文
共 50 条
  • [31] Tumor Suppressor eIF3f Inhibits Translation by Regulating rRNA Degradation
    Shi, J.
    Wen, F.
    Zhou, R.
    Shen, A.
    Choi, A.
    LABORATORY INVESTIGATION, 2012, 92 : 466A - 466A
  • [32] Estrogen receptor alpha (ERa) promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).
    Cuesta, Rafael
    Holz, Marina K.
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 56 - 56
  • [33] THE EXPRESSION OF EIF3, LARGE SUBUNIT (P150) IN HUMAN GLIOBLASTOMA
    Haybaeck, Johannes
    Schindler, Christoph
    Spizzo, Gilbert
    Brunhuber, Thomas
    Schaefer, Georg
    Spiegl-Kreinecker, Sabine
    Fischer, Johannes
    Weis, Serge
    Obrist, Peter
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3309 - 3309
  • [34] Identification of a translation initiation factor 3 (eIF3) core complex, conserved in yeast and mammals, that interacts with eIF5
    Phan, L
    Zhang, XL
    Asano, K
    Anderson, J
    Vornlocher, HP
    Greenberg, JR
    Qin, J
    Hinnebusch, AG
    MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (08) : 4935 - 4946
  • [35] Binding of eIF3 in complex with eIF5 and eIF1 to the 40S ribosomal subunit is accompanied by dramatic structural changes
    Zeman, Jakub
    Itoh, Yuzuru
    Kukacka, Zdenek
    Rosulek, Michal
    Kavan, Daniel
    Kouba, Tomas
    Jansen, Myrte E.
    Mohammad, Mahabub P.
    Novak, Petr
    Valasek, LeoS S.
    NUCLEIC ACIDS RESEARCH, 2019, 47 (15) : 8282 - 8300
  • [36] Distribution of Translation Initiation Factor eIF3 in Neutrophils in Alzheimer Disease
    Ivanov, P. A.
    Mikhaylova, N. M.
    Klyushnik, T. P.
    BIOLOGICHESKIE MEMBRANY, 2016, 33 (04): : 287 - 292
  • [37] 翻译调控者eIF3a:最复杂的eIF3亚基
    肖杨斌
    杨运泉
    周厚吾
    龚双喜
    杨丰帅
    中外医学研究, 2014, 12 (36) : 161 - 162
  • [38] Crystal structure of human eIF3k, the first structure of eIF3 subunits
    Wei, ZY
    Zhang, P
    Zhou, ZC
    Cheng, ZJ
    Wan, M
    Gong, WM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (33) : 34983 - 34990
  • [39] Structure of a Yeast 40S–eIF1–eIF1A–eIF3–eIF3j initiation complex
    Christopher H S Aylett
    Daniel Boehringer
    Jan P Erzberger
    Tanja Schaefer
    Nenad Ban
    Nature Structural & Molecular Biology, 2015, 22 : 269 - 271
  • [40] Tumor Suppressor eIF3f Inhibits Translation by Regulating rRNA Degradation
    Shi, J.
    Wen, F.
    Zhou, R.
    Shen, A.
    Choi, A.
    MODERN PATHOLOGY, 2012, 25 : 466A - 466A